News, events, publications
- Frontiers Research Topic: TLR4-Dependent Homeostasis and Immunopathology: Focus on Cross-talk with Other Signaling Pathways
- Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity
- Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis.
- Interview to F Peri on new molecules against COVID19 infections (La Repubblica, 28 Marzo 2020)
- F Peri inteview on Microbiote, Rai Cultura, Nautilus
- Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay
The Peri Lab
Research areas of the Peri Lab
- TLR4-directed small molecules (read more). Development of anti-inflammatory therapeutics (against IBD or against acute respiratory syndrome induced by viral infections) and vaccine adjuvants
- New drug hits against heart failure, with a novel mechanism of action based on the stimulation stimulation of the Serca 2a protein
- study of pharmacological properties of natural compounds
Our projects and networks
